Alveolar soft part sarcoma
Showing 1 - 25 of >10,000
Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)
Active, not recruiting
- Alveolar Soft Part Sarcoma
- Soft Tissue Sarcomas
-
Miami, FloridaUniversity of Miami
Dec 29, 2022
Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI
Recruiting
- Advanced Alveolar Soft Part Sarcoma
- +3 more
- Atezolizumab
- +5 more
-
Bethesda, Maryland
- +1 more
Jan 28, 2023
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023
Sarcoma, Alveolar Soft Part Trial run by the NCI (AZD2171)
Active, not recruiting
- Sarcoma, Alveolar Soft Part
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2022
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)
Recruiting
- Soft Tissue Sarcoma
- +9 more
- Patient with Soft Tissue Sarcoma
-
Besancon, France
- +13 more
Oct 11, 2022
Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,
Recruiting
- Sarcoma
- +3 more
- Isolated Limb Infusion
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 21, 2022
Alveolar Soft Part Sarcoma Trial in Beijing (GB226)
Recruiting
- Alveolar Soft Part Sarcoma
- GB226
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 2, 2021
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)
Completed
- Sarcoma, Clear Cell
- +3 more
- GVAX
-
Boston, Massachusetts
- +1 more
Mar 2, 2021
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory
Active, not recruiting
- Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
- +5 more
- Crizotinib (PF-02341066)
-
Brussels, Belgium
- +24 more
May 9, 2022
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021
Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,
Active, not recruiting
- Adrenal Cortex Carcinoma
- +39 more
- Cabozantinib
- +2 more
-
Birmingham, Alabama
- +142 more
May 24, 2022
Retrospective Study in Sarcoma Patients
Completed
- Sarcoma of Bone
- Sarcoma of Soft Tissue
-
Greifswald, GermanyUniversity Medicine Greifswald, Department of Internal Medicine
Nov 5, 2021
Alveolar Soft-part Sarcoma Trial in Australia, Spain, United Kingdom (Cediranib, Placebo)
Unknown status
- Alveolar Soft-part Sarcoma
- Cediranib
- Placebo
-
Brisbane, Australia
- +10 more
Jan 22, 2019
Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,
Recruiting
- Metastatic Solid Tumor
- +6 more
- Surufatinib and Tislelizumab _ Part 1
- Surufatinib and Tislelizumab _ Part 2
-
Tucson, Arizona
- +17 more
Apr 1, 2022
Sarcoma Trial (Camrelizumab and Apatinib)
Unknown status
- Sarcoma
- Camrelizumab and Apatinib
- (no location specified)
Jun 23, 2020
Soft Tissue Sarcoma Trial (Cadonilimab)
Not yet recruiting
- Soft Tissue Sarcoma
- Cadonilimab
- (no location specified)
Dec 9, 2022
Novel Applications for Sarcoma Assessment
Not yet recruiting
- Sarcoma
- Quantitative MRI
- Reproducibility study
- (no location specified)
Oct 2, 2023